135 related articles for article (PubMed ID: 29650288)
21. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
22. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Elkamhawy A; Viswanath AN; Pae AN; Kim HY; Heo JC; Park WK; Lee CO; Yang H; Kim KH; Nam DH; Seol HJ; Cho H; Roh EJ
Eur J Med Chem; 2015 Oct; 103():210-22. PubMed ID: 26355532
[TBL] [Abstract][Full Text] [Related]
23. Distamycin A enhances the cytotoxicity of duocarmycin A and suppresses duocarmycin A-induced apoptosis in human lung carcinoma cells.
Hirota M; Fujiwara T; Mineshita S; Sugiyama H; Teraoka H
Int J Biochem Cell Biol; 2007; 39(5):988-96. PubMed ID: 17321782
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
[TBL] [Abstract][Full Text] [Related]
25. GADD45A plays a protective role against temozolomide treatment in glioblastoma cells.
Wang HH; Chang TY; Lin WC; Wei KC; Shin JW
Sci Rep; 2017 Aug; 7(1):8814. PubMed ID: 28821714
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
27. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.
Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L
Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977
[TBL] [Abstract][Full Text] [Related]
28. Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis.
Ellis DA; Wolkenberg SE; Boger DL
J Am Chem Soc; 2001 Sep; 123(38):9299-306. PubMed ID: 11562212
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme.
Tomuleasa C; Soritau O; Kacso G; Fischer-Fodor E; Cocis A; Ioani H; Timis T; Petrescu M; Cernea D; Virag P; Irimie A; Florian IS
J BUON; 2010; 15(4):758-62. PubMed ID: 21229642
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific.
Castro ML; McConnell MJ; Herst PM
Free Radic Biol Med; 2014 Sep; 74():200-9. PubMed ID: 24992837
[TBL] [Abstract][Full Text] [Related]
31. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro.
Storch K; Sagerer A; Cordes N
Oncol Rep; 2015 Apr; 33(4):2009-16. PubMed ID: 25625667
[TBL] [Abstract][Full Text] [Related]
33. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
34. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
35. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.
Kil WJ; Cerna D; Burgan WE; Beam K; Carter D; Steeg PS; Tofilon PJ; Camphausen K
Clin Cancer Res; 2008 Feb; 14(3):931-8. PubMed ID: 18245557
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
[TBL] [Abstract][Full Text] [Related]
38. Exploring the cytotoxicity and anticancer effects of doxycycline and azithromycin on human glioblastoma multiforme cells.
Hassan SN; Mohamed Yusoff AA; Idris Z; Mohd Redzwan N; Ahmad F
Neurol Res; 2022 Mar; 44(3):242-251. PubMed ID: 34533110
[TBL] [Abstract][Full Text] [Related]
39. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.
Patil PC; Satam V; Lee M
Anticancer Agents Med Chem; 2015; 15(5):616-30. PubMed ID: 25511515
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of AminoCBIs: highly reactive but highly cytotoxic analogues of the duocarmycins.
Tercel M; Pruijn FB; O'Connor PD; Liyanage HD; Atwell GJ; Alix SM
Chembiochem; 2014 Sep; 15(13):1998-2006. PubMed ID: 25087870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
